You are here

Achillion Pharmaceuticals, Inc.

Company Information
Achillion Pharmaceuticals, Inc. 300 George St, Ste 801
New Haven, CT 06511 0665
United States



# of Employees: N/A

Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts

Award Listing

  1. Novel Antibacterial Agents That Target DNA Replication in Mycobacterium tuberculo

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Mycobacterium tuberculosis (MTB) is probably the most ubiquitous microbial pathogen in the world today infecting one-third of the total population and causing mill ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  2. Capsid assembly inhibitors for the treatment of AIDS

    Amount: $597,665.00

    DESCRIPTION (provided by applicant): Current HIV-1 therapy suffers from inadequate viral load suppression due to poor compliance, resistance, and interactions with other drugs and can lead to spread o ...

    SBIRPhase I2005Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government